🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
We Can Medicines Co., Ltd. (TPEX:6929)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.95
-0.90 (-4.32%)
Nov 19, 2026, 12:36 PM CST

We Can Medicines Revenue

We Can Medicines had revenue of 811.83M TWD in the quarter ending September 30, 2026, with 2.82% growth. This brings the company's total for the last twelve months to 3.23B, up 0.31% year-over-year. In the year 2025, We Can Medicines had annual revenue of 3.22B, down -1.45%. That makes We Can Medicines the 22,846th largest company in the world by revenue and 965th in Taiwan.

Revenue (ttm)
3.23B
Revenue Growth
+0.31%
P/S Ratio
0.28
Revenue / Employee
3.17M
Employees
1,020
Market Cap
899.55M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.22B-47.40M-1.45%
Dec 31, 20243.27B146.31M4.69%
Dec 31, 20233.12B-179.84M-5.45%
Dec 31, 20223.30B508.66M18.21%
Dec 31, 20212.79B127.32M4.77%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.